Erratum to "Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation" [Clin. Immunol. 123 (2007) 30-39] (DOI:10.1016/j.clim.2006.11.005);Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation

Clinical Immunology

Volumn 123, Issue 1, 2007, Pages 30-39

  Kim, Namju ^a,b   Kunisawa, Jun ^b   Kweon, Mi Na ^c   Eog Ji, Geun ^b,d   Kiyono, Hiroshi ^b  

^a Seoul National University   (South Korea)

^b University of Tokyo   (Japan)

^c International Vaccine Institute   (South Korea)

^d Bifido Inc   (South Korea)

Author keywords

Bifidobacterium bifidum BGN4; IBD; Inflammation; Probiotics; Th1

Indexed keywords

CD4 ANTIGEN; CD45RB ANTIGEN; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM BIFIDUM; CELL INFILTRATION; CELL TRANSFER; ENTERITIS; FEMALE; IMMUNOMODULATION; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 33947136296     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.11.010     Document Type: Erratum

References (46)

1. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev., Immunol. 3 7 (2003) 521-533
2. Elson C.O. Experimental models of intestinal inflammation. New insights into mechanisms of mucosal homeostasis. In: Orga P.L., et al. (Ed). Handbook of Mucosal Immunology (1999), Academic Press, San Diego 1007-1024
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 1 (1998) 182-205
4. Sartor R.B. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner J.B., and Shorter R.G. (Eds). Inflammatory Bowel Disease (1995), Williams and Wilkins, Baltimore 96-104
5. Linskens R.K., et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand. J. Gastroenterol., Suppl. 234 (2001) 29-40
6. Bamias G., et al. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J. Immunol. 169 9 (2002) 5308-5314
7. Ouwehand A.C., Salminen S., and Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82 1-4 (2002) 279-289
8. Shortt C. The probiotic century: historical and current perspectives. Trends Food Sci. Technol. 10 12 (1999) 411-417
9. Borruel N., et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51 5 (2002) 659-664
10. McCarthy J., et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52 7 (2003) 975-980
11. Madsen K.L., et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116 5 (1999) 1107-1114
12. Steidler L., et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 5483 (2000) 1325-1352
13. Bezkorovanyl A. Ecology of bifidobacteria. In: Bezkorovainy A., and Miller-Catchpole R. (Eds). Biochemistry and Physiology of Bifidobacteria (1989), CRC Press, Florida 29-72
14. Teitelbaum J.E., and Walker W.A. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22 (2002) 107-138
15. Steidler L. Microbiological and immunological strategies for treatment of inflammatory bowel disease. Microbes Infect. 3 13 (2001) 1157-1166
16. Kim I.H., Park M.S., and Ji G.E. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like caco-2 cells. J. Microbiol. Biotechnol. 13 2 (2003) 276-281
17. + T cells. J. Exp. Med. 178 1 (1993) 237-244
18. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179 2 (1994) 589-600
19. high T cells to SCID recipients. J. Immunol. 158 7 (1997) 3464-3473
20. Ott S.J., et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53 5 (2004) 685-693
21. Choi Y.J., et al. Growth and beta-glucosidase activity of Bifidobacterium. J. Microbiol. Biotechnol. 6 4 (1996) 255-259
22. + TCR ββ homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR α-chain-deficient mice. J. Immunol. 165 10 (2000) 5891-5899
23. + T-cell population mediates development of inflammatory bowel disease in T-cell receptor α chain-deficient mice. Gastroenterology 112 6 (1997) 1876-1886
24. Kweon M.N., et al. Development of antigen induced colitis in SCID mice reconstituted with spleen derived memory type CD4(+) CD45RB(+) T cells. Gut 50 3 (2002) 299-306
25. Parlesak A., et al. Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand. J. Immunol. 60 5 (2004) 477-485
26. Abbas A.K., Lichtman A.H., and Pober J.S. Cell and tissue of the immune system. In: Shmitt W. (Ed). Cellular and Molecular Immunology (1997), WB Saunders, Philadelphia 15-33
27. Corazza N., et al. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+) CD45RB(hi) T cells. J. Exp. Med. 190 10 (1999) 1479-1492
28. Lievin V., et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47 5 (2000) 646-652
29. Toure R., et al. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J. Appl. Microbiol. 95 5 (2003) 1058-1069
30. high T cells. Eur. J. Immunol. 31 5 (2001) 1465-1474
31. Shiba T., et al. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol. Immunol. 47 6 (2003) 371-378
32. Sands B.E. Therapy of inflammatory bowel disease. Gastroenterology 118 2 Suppl. 1 (2000) 68-82
33. + regulatory T cells and IL-10. J. Immunol. 171 2 (2003) 971-978
34. Leach M.W., et al. The role of IL-10 in inflammatory bowel disease: "of mice and men". Toxicol. Pathol. 27 1 (1999) 123-133
35. + regulatory T cells. J. Immunol. 171 2 (2003) 708-716
36. + T cells. J. Immunol. 172 12 (2004) 7306-7314
37. Rigby R.J., et al. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin. Exp. Immunol. 139 2 (2005) 245-256
38. Rescigno M., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2 4 (2001) 361-367
39. Huang F.P. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191 3 (2000) 435-444
40. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 2 (2004) 229-241
41. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 5664 (2004) 1662-1665
42. Christensen H.R., Frokiar H., and Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168 1 (2002) 171-178
43. Drakes M., Blanchard T., and Czinn S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72 6 (2004) 3299-3309
44. Seidelin J.B. Colonic epithelial cell turnover: possible implications for ulcerative colitis and cancer initiation. Scand. J. Gastroenterol. 39 3 (2004) 201-211
45. Cario E., et al. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160 1 (2002) 165-173
46. Rachmilewitz D., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126 2 (2004) 520-528